Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.32 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL963459 | 0.98 | AOC3 (0.32) | AOC3ADORA2AADORA2BTDP2 | |
| SCHEMBL13844408 | 0.76 | TDP2 (0.35) | AOC3ADORA2AADORA2BTDP2 | |
| SCHEMBL4470815 | 0.76 | TDP2 (0.46) | AOC3ADORA2AADORA2BTDP2 | |
| SCHEMBL13104161 | 0.71 | AOC3 (0.36) | AOC3ADORA2AADORA2B | |
| SCHEMBL16787520 | 0.69 | PDE10A (0.32) | AOC3TDP2 | |
| SCHEMBL4477330 | 0.69 | AOC3 (0.33) | AOC3ADORA2AADORA2BTDP2 | |
| SCHEMBL16787523 | 0.66 | MEN1 (0.31) | — | |
| SCHEMBL11470209 | 0.66 | — | — | |
| SCHEMBL21889064 | 0.64 | TDP2 (0.42) | AOC3TDP2 | |
| SCHEMBL2454493 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015181-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2011-01-20 | — | — | US | disclosed |
| EP-2264026-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | Banyu Pharmaceutical Co., Ltd. (JP) | 2010-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015181-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | NPY4R, NPY1R, NPY2R | AOC3 826/4885ADORA2A 1192/4885ADORA2B 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.